239 related articles for article (PubMed ID: 12707727)
21. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
22. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
23. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.
Aversa F; Terenzi A; Tabilio A; Falzetti F; Carotti A; Ballanti S; Felicini R; Falcinelli F; Velardi A; Ruggeri L; Aloisi T; Saab JP; Santucci A; Perruccio K; Martelli MP; Mecucci C; Reisner Y; Martelli MF
J Clin Oncol; 2005 May; 23(15):3447-54. PubMed ID: 15753458
[TBL] [Abstract][Full Text] [Related]
24. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR
Biol Blood Marrow Transplant; 2006 Jul; 12(7):749-57. PubMed ID: 16785064
[TBL] [Abstract][Full Text] [Related]
25. Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.
Kobbe G; Fenk R; Neumann F; Bernhardt A; Steidl U; Kondakci M; Graef T; Aivado M; Vaupel M; Huenerlituerkoglu AN; Kronenwett R; Pape H; Hildebrand B; Germing U; Haas R
Cytotherapy; 2004; 6(6):533-42. PubMed ID: 15764020
[TBL] [Abstract][Full Text] [Related]
26. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
[TBL] [Abstract][Full Text] [Related]
27. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation.
Huang X; Guo N; Ren H; Zhang Y; Gao Z; Lu D
Chin Med J (Engl); 2003 May; 116(5):736-41. PubMed ID: 12875692
[TBL] [Abstract][Full Text] [Related]
28. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
[TBL] [Abstract][Full Text] [Related]
29. [Acute myeloid leukemia originating from the same leukemia clone after the complete remission of acute lymphoid leukemia].
Matsuda I; Nakamaki T; Amaya H; Kiyosaki M; Kawakami K; Yamada K; Yokoyama A; Hino K; Tomoyasu S
Rinsho Ketsueki; 2003 Sep; 44(9):946-51. PubMed ID: 14577315
[TBL] [Abstract][Full Text] [Related]
30. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
Schleuning M; Günther W; Tischer J; Ledderose G; Kolb HJ
Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194
[TBL] [Abstract][Full Text] [Related]
31. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal bone marrow transplantation between brother and sister.
Rana I; Pinto RM; Caniglia M; Lombardi A; De Rossi G
Bone Marrow Transplant; 2002 Apr; 29(8):705-7. PubMed ID: 12180117
[TBL] [Abstract][Full Text] [Related]
33. [CD7 positive acute myelogenous leukemia exhibiting pleural involvement as an initial manifestation].
Ohe K; Okamura T; Arima F; Kamura T; Takamatsu Y; Murakawa M; Okamura S; Harada M; Niho Y
Rinsho Ketsueki; 1994 Jun; 35(6):552-6. PubMed ID: 7521403
[TBL] [Abstract][Full Text] [Related]
34. [Continuation of complete remission by oral administration of cytarabine ocfosfate in a patient with M0, who achieved remission by small doses of cytosine arabinoside with G-CSF].
Aoki S; Koyama S; Goto T; Takahashi H; Shibata A
Rinsho Ketsueki; 1995 Jan; 36(1):40-4. PubMed ID: 7536275
[TBL] [Abstract][Full Text] [Related]
35. Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Komeno Y; Kanda Y; Kandabashi K; Kawazu M; Goyama S; Takeshita M; Nannya Y; Niino M; Nakamoto T; Kurokawa M; Tsujino S; Ogawa S; Aoki K; Chiba S; Motokura T; Hirai H
Am J Hematol; 2003 Mar; 72(3):220-2. PubMed ID: 12605397
[TBL] [Abstract][Full Text] [Related]
36. Intensive chemotherapy followed by donor PBSC in ANLL relapsed after allogeneic BMT.
Bernasconi P; Alessandrino EP; Caldera D; Bonfichi M; Boni M; Troletti D; Pagnucco G; Cavigliano P; Perotti C; Biaggi G
Bone Marrow Transplant; 1995 Apr; 15(4):643-5. PubMed ID: 7655395
[TBL] [Abstract][Full Text] [Related]
37. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR
Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531
[TBL] [Abstract][Full Text] [Related]
39. A second unrelated bone marrow transplant with an unrelated donor marrow: treatment of a patient with relapsed leukemia.
Basara N; Bischoff M; Blau IW; Hermann D; Römer E; Rudolphi M; Kirsten D; Sanchez H; Fauser AA
Bone Marrow Transplant; 1998 Feb; 21(3):291-3. PubMed ID: 9489653
[TBL] [Abstract][Full Text] [Related]
40. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes.
Giagounidis AA; Heinsch M; Haase S; Aul C
Ann Hematol; 2004 Nov; 83(11):716-21. PubMed ID: 15316755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]